According to our (Global Info Research) latest study, the global Cardiac Markers Point-of-care Detection market size was valued at US$ 4563 million in 2025 and is forecast to a readjusted size of US$ 8076 million by 2032 with a CAGR of 8.6% during review period.
The immediate detection of cardiac markers is mainly a rapid quantitative or qualitative detection and screening of common cardiovascular diseases, including rapid detection reagents and quantitative analysis instruments such as myocardial injury markers, heart failure markers, platelet function and coagulation mechanism.
The cardiac marker point-of-care testing market has witnessed significant growth in recent years, driven by rising prevalence of cardiovascular diseases, advancements in POC technology, and emphasis on personalized medicine.
This report is a detailed and comprehensive analysis for global Cardiac Markers Point-of-care Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiac Markers Point-of-care Detection market size and forecasts, in consumption value ($ Million), 2021-2032
Global Cardiac Markers Point-of-care Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Cardiac Markers Point-of-care Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Cardiac Markers Point-of-care Detection market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiac Markers Point-of-care Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiac Markers Point-of-care Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alere, Roche, Abbott, BioMérieux, LSI Medience Corporation, Randox laboratories Ltd, Guangzhou Wondfo Biotechnology Co., Ltd., Getein Biotech, ReLIA, Lepu Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cardiac Markers Point-of-care Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Medical Equipment
Consumables
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Alere
Roche
Abbott
BioMérieux
LSI Medience Corporation
Randox laboratories Ltd
Guangzhou Wondfo Biotechnology Co., Ltd.
Getein Biotech
ReLIA
Lepu Medical
Goldsite
Lifotronic
Hotgen
Ediagnosis
POCT
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cardiac Markers Point-of-care Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cardiac Markers Point-of-care Detection, with revenue, gross margin, and global market share of Cardiac Markers Point-of-care Detection from 2021 to 2026.
Chapter 3, the Cardiac Markers Point-of-care Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cardiac Markers Point-of-care Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cardiac Markers Point-of-care Detection.
Chapter 13, to describe Cardiac Markers Point-of-care Detection research findings and conclusion.
Summary:
Get latest Market Research Reports on Cardiac Markers Point-of-care Detection. Industry analysis & Market Report on Cardiac Markers Point-of-care Detection is a syndicated market report, published as Global Cardiac Markers Point-of-care Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cardiac Markers Point-of-care Detection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.